We only have this paper's title and publication details.
Read it at the sourceClinical study reports botulinum toxin type A efficacy in early-stage small-angle acute acquired comitant esotropia, suggesting a therapeutic intervention for ocular deviation.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: